LYMPHOPROLIFERATIVE DISORDER
Clinical trials for LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental Virus-Targeting drugs tested for deadly rare disorder
Disease control OngoingThis study aims to understand and treat a rare, often fatal disorder called KSHV-associated multicentric Castleman's disease, which is caused by a virus and linked to certain cancers. Researchers are testing several experimental drug combinations in 75 adult participants to see i…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New transplant strategy aims to tame blood cancers and reduce rejection
Disease control OngoingThis study is testing a modified stem cell transplant procedure for patients with high-risk blood cancers. The goal is to see if using specific chemotherapy drugs in a timed sequence before and after the transplant can better control the cancer while reducing harmful immune react…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC